Tag
IHL‑216A
Incannex receives positive feedback from FDA for its brain injury treatment drug
Rowan Dunne · Oct 11, 2022
Incannex partners with Curia to accelerate production of IHL‑216A
Rowan Dunne · Aug 2, 2022